(IN BRIEF) The Fresenius healthcare group is constructing a new facility, KabiLab D20, at Daimlerstrasse 20 on its Bad Homburg campus, set to cover 5,000 m². This modern laboratory and office building will feature state-of-the-art laboratories, 90 shared workstations, meeting … Read the full press release
Posted in Business, Construction, Environment, Financial, Germany, Healthcare, Industrial, Infrastructure & Utilities, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged 000 m², 5, Bad Homburg, clinical nutrition leader, CO₂ reduction, Daimlerstrasse 20, Diabetes, employee relocation, Fresenius healthcare group, Fresenius Kabi Business Unit Nutrition, Fresubin enteral nutrition, heat pump, innovative products, KabiLab D20, laboratory and office building, metabolic disorders, Oberursel, patient-specific parenteral nutrition, Photovoltaic Systems, Rainwater harvesting, sustainability
(IN BRIEF) GEA has introduced a major update to its NexGen Tablet Press by launching a new set of enhanced labels designed to improve clarity and usability. The updated labels feature high-contrast visuals, refreshed icons, and integrated QR codes, enabling … Read the full press release
Posted in Business, Environment, Financial, Food & Beverage, Germany, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Technology
Tagged customer feedback, efficiency, enhanced labeling, equipment update, GEA, high-contrast graphics, INNOVATION, NexGen Tablet Press, process technology, QR codes, regulatory compliance, safety, sustainability, tablet production, upgrade, user-friendly
(IN BRIEF) The University of Helsinki has announced that its incubator programs have successfully launched more than 80 startups, highlighting the institution’s dedication to promoting innovation and entrepreneurship. These startups, which cover a spectrum of industries such as technology, digital … Read the full press release
Posted in Business, Education, Financial, Finland, Healthcare, Industrial, Investment, Management, News, Science, Technology
Tagged academic-industry collaboration, digital services, economic growth, Entrepreneurship, incubators, INNOVATION, innovation ecosystem, job creation, life sciences, mentorship, research commercialization, Startups, sustainable solutions, technology, University of Helsinki
(IN BRIEF) MR CoilTech, a partner in the University of Glasgow’s Living Laboratory programme, has been awarded the Innovative Collaboration Award at the 2025 Scotland’s Life Sciences Awards. The award, which recognizes breakthrough partnerships that integrate industry, academic, and clinical … Read the full press release
Posted in Awards, Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged 7 Tesla MRI, advanced diagnostics, Awards, clinical validation, Coil Development project, Dr Shajan Gunamony, healthcare collaboration, imaging innovation, Innovative Collaboration Award, leadership, life sciences, Living Laboratory, MR CoilTech, NHS Greater Glasgow and Clyde, radiofrequency head coil, Research Excellence, Scotland’s Life Sciences Awards, University of Glasgow, Wideblue Limited
(IN BRIEF) The FORESIGHT consortium, comprising leading researchers from UMC Groningen, Amsterdam UMC, NKI/AVL, and TU/e, has launched a pioneering initiative to advance immunotherapy drug development by leveraging molecular imaging and AI technologies. With a grant of at least €9 … Read the full press release
Posted in Artificial Intelligence (AI), Business, Education, Financial, Healthcare, Industrial, Investment, Management, Netherlands, News, Science, Technology
Tagged AI, Amsterdam UMC, autoimmune, cardiovascular, clinical studies, Fons van der Sommen, FORESIGHT consortium, Guus van Dongen, Health~Holland, imaging biomarkers, immunotherapy drug development, John Haanen, Liesbeth de Vries, Life Sciences & Health, molecular imaging, neurodegenerative, NKI/AVL, nuclear imaging, oncological, optical imaging, personalized medicine, Peter de With, precision medicine, preclinical studies, Public Private Partnership, Roy van der Meel, TU/e, UMC Groningen, Willem Mulder, €18 million funding, €9 million grant
(IN BRIEF) The MATTERHORN Phase III trial has demonstrated that a perioperative regimen combining AstraZeneca’s Imfinzi (durvalumab) with FLOT chemotherapy significantly improves event-free survival in patients with resectable gastric and gastroesophageal junction cancers compared to standard chemotherapy alone. Interim findings … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged adjuvant, AstraZeneca, clinical trial, Cristian Massacesi, durvalumab, early-stage, EFS, event-free survival, FLOT chemotherapy, gastric cancer, gastroesophageal junction, GEJ cancers, global, Imfinzi, immunotherapy, locally advanced, MATTERHORN, Memorial Sloan Kettering, neoadjuvant, OS, overall survival, pathologic complete response, PCR, Phase III Trial, randomized, resectable, safety profile, tumor regression, Yelena Y. Janjigian
(IN BRIEF) Marks & Spencer has teamed up with Olympic champion Sir Chris Hoy and Prostate Cancer UK to promote prostate cancer awareness through an online risk checker campaign. Donating £4 from every pack of Autograph men’s underwear sold, the … Read the full press release
Posted in Apparel, Fashion & Beauty, Business, Financial, Healthcare, Industrial, Investment, Management, News, Retail, Technology, United Kingdom
Tagged 61000 higher risk, 75000 completions, Autograph men's underwear, campaign, early screening, M&S, Marks & Spencer, men's health, online Risk Checker, partnership, Prostate Cancer UK, PSA blood test, public awareness, QR code, Sir Chris Hoy, UK market, £4 donation, £55000 raised
(IN BRIEF) Roche announced the launch of the Roche Genentech Innovation Center Boston at Harvard’s Enterprise Research Campus in Allston, establishing a hub that will drive breakthroughs in Cardiovascular, Renal, and Metabolism research while also leveraging data science and AI … Read the full press release
Posted in Business, Financial, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged AI, Alan Garber, Allston, Boston, cardiovascular, data science, drug discovery, Genentech, Harvard Enterprise Research Campus, Healthcare Innovation, Manu Chakravarthy, Maura Healey, METABOLISM, Michelle Wu, Mixed-Use Campus, partnership, Public Private Partnership, Renal, research and development, Roche, Roche Genentech Innovation Center Boston, Thomas Schinecker, USD11 Billion Investment
(IN BRIEF) QIAGEN has received FDA approval for its QIAstat-Dx Gastrointestinal Panel 2 Mini B, expanding its syndromic testing offerings for gastrointestinal infections in the U.S. This new panel targets five major bacterial pathogens and complements the previously cleared QIAstat-Dx … Read the full press release
Posted in Business, Financial, Government, Healthcare, Industrial, Investment, Management, Netherlands, News, Pharma & Biotech, Science, Technology
Tagged bacterial pathogens, Campylobacter, clinical needs, diagnostic solutions, diagnostic workflows, FDA clearance, Gastrointestinal Infections, healthcare flexibility, healthcare providers, Infectious Diseases Society of America, laboratories, Nadia Aelbrecht, outpatient use, partnership, QIAGEN, QIAstat-Dx Gastrointestinal Panel 2 Mini B, QIAstat-Dx Gastrointestinal Panel 2 Mini B&V, QIAstat-Dx Rise, QIAstat-Dx system, real-time PCR, Salmonella, Shigella, STEC, syndromic testing, Yersinia enterocolitica
(IN BRIEF) Researchers from the University of Twente, in collaboration with Amalia Children’s Hospital Nijmegen and Emma Children’s Hospital Amsterdam, have developed a solution to reduce the number of neonatal transfers in the Netherlands. Their study suggests that by allowing … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, Netherlands, News, Science, Technology
Tagged Amalia Children's Hospital Nijmegen, Capacity, CHOIR research centre, collaboration, Emma Children's Hospital Amsterdam, flexible staffing, Gréanne Leeftink, Health Care Management Science, Health Risks, inter-organizational pooling, Kimberley Morris, neonatal intensive care unit, neonatal transports, Netherlands, NICU, nurse deployment, Operations Management, parents, patient transfers, pilot project, Randstad region, simulation-optimization, specialized nurses, TechMed Center, University of Twente
(IN BRIEF) Yun Bing, a Postdoctoral Researcher at the University of Liverpool, has won the Innovate UK Women in Innovation Award for her AI-based speech therapy platform, Beautiful Voice. The award, which celebrates women leading in innovation, was presented by … Read the full press release
Posted in Artificial Intelligence (AI), Awards, Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged 000 grant, 10 Downing Street, 75, AI speech therapy platform, Awards, Beautiful Voice, business coaching, communication rehabilitation, computational modeling, digital health, Healthcare, inequalities in access, Innovate UK Women in Innovation Award, INNOVATION, leadership, Networking, Prime Minister Sir Keir Starmer, speech and language therapy, stroke rehabilitation, technology, treatment outcomes, University of Liverpool, Yun Bing
(IN BRIEF) Professor Christopher Stewart from Newcastle University has become the first from his institution to win the esteemed Blavatnik Award for Young Scientists in the Life Sciences category. Honored with £100,000 in unrestricted funds, he is recognized for his … Read the full press release
Posted in Awards, Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged 000, 15-year research journey, Awards, black-tie gala, Blavatnik Award, Blavatnik Family Foundation, climate change, clinical practices, green manufacturing, gut microbiome, human breast milk, infant mortality, international recognition, King’s College London, Lady Emily Blavatnik, leadership, life sciences, microbiome-based therapies, Newcastle University, pre-natal infant mortality, premature gut organoid models, Professor Christopher Stewart, Professor Shitij Kapur, Sir Leonard Blavatnik, The New York Academy of Sciences, The Orangery at Kensington Palace, YOUNG SCIENTISTS, £100
(IN BRIEF) The European Investment Bank has committed €150 million to a pioneering financing initiative exclusively supporting women entrepreneurs in Spain’s pharmacy sector. The investment, delivered through a covered bond issued by CBNK—a bank formed by the merger of Banco … Read the full press release
Posted in Banks, Business, Economy, European Union, Financial, Government, Healthcare, Industrial, Investment, Luxembourg, Management, News, Pharma & Biotech, Science, Society, Spain, Technology
Tagged 000 loans, 600 pharmacies, Banco Caminos, Bancofar, CBNK, commercial bank advisory programme, EIB, EIB Group Forum, Enrique Serra González, equipment, European Commission, European Investment Bank, gender equality, Gender Finance Lab, inclusive economic growth, intermediated financing programme, InvestEU Advisory Hub, license acquisition, Luxembourg, Moody's Aa1 rating, Nadia Calviño, partnership, pharmacy sector, Spain, Spanish healthcare system, women entrepreneurs, working capital, €150 million investment, €450
(IN BRIEF) Researchers at the Institute of Cancer Research in London have identified genetic markers that predict a significant survival benefit from combining ipatasertib with abiraterone in treating metastatic castration-resistant prostate cancer. In the phase III IPATential150 trial, patients whose … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged abiraterone, AKT inhibitor, biomarkers, clinical trial, genetic markers, Institute of Cancer Research London, ipatasertib, IPATential150 trial, metastatic castration-resistant prostate cancer mCRPC, overall survival, personalized medicine, PIK3CA/AKT1/PTEN pathway, Professor Johann de Bono, PTEN gene, Roche, sequencing techniques, synthetic lethality, targeted therapy, UK patients
(IN BRIEF) Scientists at the Institute of Cancer Research in London have developed an innovative algorithm named SYLVER, which analyzes data from over 9,300 patients to identify synthetic lethal gene pairs that cancer cells depend on for survival. Unlike previous … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged 300 patients, 9, algorithm, backup genes, BRCA mutations, Breast Cancer Now, buffering mechanism, Cancer, Cancer Genome Atlas, Cancer Research UK, Dr Hattie Brooks, Dr Simon Vincent, Dr Syed Haider, inhibitor drugs, Institute of Cancer Research, London, NIHR Biomedical Research Centre, Professor Chris Lord, protein targets, Royal Marsden NHS Foundation Trust, SYLVER, synthetic lethality, targeted therapies, tumour-suppressor genes, Walk the Walk
(IN BRIEF) On 27 February, President Alar Karis visited the Institute of Biotechnology in Finland to learn about its research and infrastructure, particularly its work in structural biology and coronavirus research. The visit highlighted the potential for increased collaboration between … Read the full press release
Posted in Business, Education, Estonia, Financial, Finland, Government, Healthcare, Industrial, Investment, Management, News, Science, Technology
Tagged Academia Europaea, Alar Karis, Brussels, collaboration, coronavirus research, cryo-electron microscopy, Estonia, Estonian Academy of Sciences, Finland, Finnish Academy of Technical Sciences, Foundation, GeneCode, INNOVATION, Institute of Biotechnology, Juha Huiskonen, Mart Saarma, Molecular Biology, Parkinson's disease, partnership, research collaboration, research infrastructure, scientific advancements, structural biology, University of Helsinki, University of Tartu
(IN BRIEF) QIAGEN has filed a lawsuit against bioMérieux in the German Unified Patent Court to protect its QuantiFERON technology, specifically its European Patent EP 2 276 883 B2, which covers innovations in QuantiFERON-TB Gold Plus used for TB detection. … Read the full press release
Posted in Business, Financial, Germany, Government, Healthcare, Industrial, Investment, Law, Management, Netherlands, News, Pharma & Biotech, Science, Security & Safety, Technology
Tagged bioMérieux, CDC, Düsseldorf, European Patent EP 2 276 883 B2, infectious disease diagnostics, intellectual property, latent tuberculosis, Molecular Diagnostics, patent lawsuit, public health, QIAGEN, QuantiFERON technology, QuantiFERON-TB Gold Plus, SD Biosensor, TB detection, Thierry Bernard, tuberculosis, tuberculosis control, Unified Patent Court, WHO
(IN BRIEF) The University of Liverpool is leading two critical projects focused on decarbonising healthcare. The Greener Trials project, led by Professor Paula Williamson, aims to reduce the carbon footprint of clinical trials through an open science approach, collaborating with … Read the full press release
Posted in Business, Education, Environment, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged carbon footprint, carbon hotspots, clinical research, clinical trials, decarbonisation, Emissions Reduction, Greener Trials, healthcare sustainability, National Institute for Health and Care Research, net zero, NHS, NHS carbon footprint, One Health Systems, Open Science, pharmaceutical industry, Professor Paula Williamson, Professor Tim Jones, South African Medical Research Council, sustainability in healthcare, Sustainable Healthcare Coalition, UK healthcare, UK Research and Innovation, University of Exeter, University of Liverpool, Wellcome
(IN BRIEF) Researchers have made a significant breakthrough in cancer drug discovery by identifying a new binding site on the eukaryotic initiation factor 4E (eIF4E), a protein long considered undruggable. The collaborative study between The Institute of Cancer Research (ICR) … Read the full press release
Posted in Healthcare, Pharma & Biotech, Science, Technology, United Kingdom
Tagged anticancer therapies, Astex Pharmaceuticals, breast cancer, Cancer Drug Discovery, Cancer Research UK, cancer treatment, Centre for Cancer Drug Discovery, drug development, druggable binding sites, eIF4E, eIF4G, fragment-based screening, ICR, Institute of Cancer Research, Nature Communications, new drug targets, Olivia Rossanese, Paul Clarke, prostate cancer, protein degradation, protein synthesis, protein synthesis regulation, small molecule inhibitors, therapeutic innovation, undruggable protein
(IN BRIEF) The European Investment Bank (EIB) has signed a €20 million loan agreement with Universal DX, a Spanish startup pioneering blood-based liquid biopsy solutions for early cancer detection. The investment will accelerate the development and commercialization of their colorectal, … Read the full press release
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?